How Does a Children’s Hospital Excel in the Discovery and Development of New Therapies?
How Does a Children’s Hospital Excel in the Discovery and Development of New Therapies? https://pediatricsnationwide.org/wp-content/uploads/2020/03/020918ds199-1-1024x651.jpg 1024 651 Abbie Miller https://pediatricsnationwide.org/wp-content/uploads/2023/05/051023BT016-Abbie-Crop.jpgA conversation with Dennis Durbin, MD, MSCE chief scientific officer, Abigail Wexner Research Institute, Nationwide Children’s Hospital Nationwide Children’s has become an epicenter for gene therapy discovery and development. The discovery in 2009 that adeno-associated virus (AAV) could cross the blood-brain barrier was a milestone in the development of dozens of gene therapy products for neuromuscular…






































